Skip to content
Pulse Online Hub

Administering Stem Cells During Pregnancy to Infants with Neural Tube Defect Improves Life Outcomes, Research Shows

A pioneering medical trial has discovered that providing pluripotent cells to fetuses suffering from spina bifida during corrective surgery can be a "important advancement" in addressing congenital conditions.

Trial Details and Safety

The American study examined six developing infants with a severe neural tube defect. Surgeons applied placenta-derived mesenchymal stem cells directly onto the developing neural column as part of the surgical correction.

Importantly, the stem cell application was found to be safe. The study team reported that the treatment did not lead to tumors, interfere with wound healing, or prevent the reversal of related neurological issues.

Encouraging Results

Imaging conducted after delivery indicated a successful correction of hindbrain herniation in all six infants. This favorable anatomical change is closely linked to enhanced physical outcomes.

"In the event it allows more children to achieve ambulation who otherwise would not, then it would become the conventional approach," commented the principal investigator. "The results are extremely promising and create a pathway toward a variety of prospective novel therapies."

Future Implications and Hope

Independent medical specialists have suggested that further confirmation of these apparent benefits could announce a "new era" in in-utero treatment. The potential to improve nerve function impairment occurring during fetal development is regarded as a revolutionary objective.

Particularly welcome would be better management of continence and digestive health, which are common challenges for people affected by this condition.

Future Directions

While this initial trial involved a limited number of patients, its confirmed tolerability and hopeful trends create a solid basis for expanded clinical research. The combination of regenerative medicine with current in-utero repair procedures holds considerable promise for improving the prognosis for babies yet to be born with this neural tube defect.

About the author

Aaron Torres

A tech journalist and digital strategist with over a decade of experience covering emerging technologies and their impact on society and business.

Pulse Online Hub

Type to search articles.